The two companies will develop AUSTEDO (deutetrabenazine) tablets for the treatment of tics associated with Tourette syndrome in pediatric patients in the US.
Azrieli yesterday bought land in Petah Tikva from Amos Luzon and Tidhar.
The company's wound treatment product has successfully passed Phase II trials.
Ceva ranked 52nd overall on the list and Orbotech 79th.
For a year now, Bank Hapoalim has been raising capital privately, avoiding the need to publish a prospectus.
Energy exploration partnership Navitas raised only NIS 32 million of the NIS 50 million it wanted.
Outbrain says that its new system makes it the world's largest distribution system for native advertising.
Together with the sale of Paragard, Teva will realize $2.48 billion for repayment of loan debt.
Cyberbit's defense business is being transferred to the parent company.
The company has received orders totaling over $5 million to provide security solutions for correctional facilities.
The interest rate on the bond, which will not be marketable, was set at 3.8%, well below the maximum.
The system was supplied by Mexico’s Balam Security.
The case will shortly be handed over to the State Attorney for a decision on whether to file indictments.
The ink is designed for 3D printing of organs and tissues for healing wounds.
A Bank of Israel study finds that a 1% change in the interest rate causes only a 1.1% change in real housing prices.
Weiss will replace Mellanox co-founder Alon Webman at the head of Mellanox's silicon engineering team.
The company bought 1,298 housing units and 60 commercial units in Berlin for NIS 885 million.
The prospective merger will reduce the number of TASE members to 22.
In its first financials as a public company, Ethernity reported a steep rise in gross margins, but financing costs weighed on net profit.
Teva's 2016 social impact report shows women doing well in lower management but under-represented in the most senior posts.
Four TASE-listed funds for investing in high-tech companies are the first stage in a new state-sponsored program.
The reading is in line with market expectations. Housing prices maintained their upward momentum.
The initial purchase is 4.9%. Sirius will buy Delek Group's remaining 47.4% at a later stage subject to regulatory approval.
The Israel Tax Authority has obtained a list of Israelis holding accounts at German banks.
Kamada's share price has plunged 40% in the past three months, following failure in a drug trial.
The ministry's director general is recommending a free market for milk.
Amdocs paid NIS 200 million for the land on which Teva had planned to build its headquarters.
Production will be in the Netherlands under the Obela brand owned jointly by Strauss Group and Pepsico.
Bet Shemesh Engines' revenue under the agreement first signed last December will rise by $530 million to $640 million.
Controlling shareholder Leon Koffler is negotiating a sale to an international fund that can assist the Israeli drugstore chain in expanding overseas.
Kardan NV wants to sell Tahal to repay its bondholders.